Skip to main content

Tonix Pharmaceuticals Holding Corp.

TNXP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001430306

In the last 90 days, Tonix Pharmaceuticals Holding Corp. insiders filed 2 open-market purchases and 0 sales; 102 institutions reported holding it in 13F filings for Q2 2026, worth $119.4M in total; no superinvestor holds it.

Q2 2023 vs. Q1 2023

How the institutions holding Tonix Pharmaceuticals Holding Corp. changed between Q1 2023 and Q2 2023.

All holders in Q2 2023All holders in Q1 2023

13F holders of TNXP: Q1 2023 compared with Q2 2023
MeasureQ1 2023Q2 2023Change
Holders3831−7
SharesConverted for a 4-for-25 split1.23M1.02M−202.8K (−16.5%)
Value$4.53M$1.62M−$2.91M (−64.3%)

New holders (2)

Institutions that held Tonix Pharmaceuticals Holding Corp. at the end of Q2 2023 but not at the end of Q1 2023.

Institutions new to TNXP in Q2 2023
InstitutionSharesValue% of portfolio
Citigroup Inc15$240.00%
Lindbrook Capital, LLC7$110.00%

Sold out (9)

Institutions that held Tonix Pharmaceuticals Holding Corp. at the end of Q1 2023 and filed for Q2 2023 without it.

Institutions that sold out of TNXP in Q2 2023
InstitutionShares, Q1 2023Value, Q1 2023
Tang Capital Management LLC1,100,419$650.5K
Hantz Financial Services, Inc.85,690$51.0K
Virtu Financial LLC58,883$35.0K
Sawtooth Solutions, LLC36,670$21.7K
UBS Group AG25,795$15.2K
Edmond de Rothschild Holding S.A.9,375$5.54K
Federated Hermes, Inc.736$435
New York State Common Retirement Fund1$1
Advisory Services Network, LLC1$1